Free Trial

InMode (INMD) Competitors

InMode logo
$14.81 +0.60 (+4.22%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$14.69 -0.12 (-0.81%)
As of 08/22/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INMD vs. NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, AORT, EYE, and ENOV

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), and Enovis (ENOV). These companies are all part of the "medical equipment" industry.

InMode vs. Its Competitors

InMode (NASDAQ:INMD) and Envista (NYSE:NVST) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

68.0% of InMode shares are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Comparatively, 0.7% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InMode has a net margin of 44.50% compared to Envista's net margin of 2.11%. InMode's return on equity of 18.38% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
InMode44.50% 18.38% 16.35%
Envista 2.11%4.84%2.68%

InMode presently has a consensus price target of $18.04, suggesting a potential upside of 21.82%. Envista has a consensus price target of $20.92, suggesting a potential downside of 3.44%. Given InMode's higher probable upside, equities analysts plainly believe InMode is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33

InMode has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Envista has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

In the previous week, Envista had 3 more articles in the media than InMode. MarketBeat recorded 7 mentions for Envista and 4 mentions for InMode. InMode's average media sentiment score of 1.61 beat Envista's score of 1.32 indicating that InMode is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InMode
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Envista
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

InMode has higher earnings, but lower revenue than Envista. InMode is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InMode$394.82M2.37$181.27M$2.476.00
Envista$2.55B1.41-$1.12B$0.3267.72

Summary

InMode beats Envista on 11 of the 17 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$898.20M$10.84B$5.76B$9.58B
Dividend YieldN/A1.87%4.41%4.10%
P/E Ratio6.0020.9031.1026.05
Price / Sales2.3729.67432.51103.82
Price / Cash7.7924.5537.7358.48
Price / Book1.493.519.536.61
Net Income$181.27M$211.77M$3.26B$265.56M
7 Day Performance3.21%4.44%2.10%1.97%
1 Month Performance-0.80%8.85%2.81%-0.36%
1 Year Performance-8.86%-9.03%30.56%19.03%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
1.9906 of 5 stars
$14.81
+4.2%
$18.04
+21.8%
-4.4%$898.20M$394.82M6.00480Positive News
NVST
Envista
3.8499 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+20.6%$3.45B$2.51B64.8312,300
LIVN
LivaNova
1.736 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+21.4%$2.91B$1.25B-13.692,900Positive News
Analyst Forecast
WRBY
Warby Parker
2.1262 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+94.9%$2.88B$771.32M-391.093,780Analyst Upgrade
INSP
Inspire Medical Systems
4.9366 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-48.6%$2.61B$802.80M51.031,246Positive News
Short Interest ↓
LQDA
Liquidia Technologies
3.5732 of 5 stars
$27.72
+6.8%
$31.40
+13.3%
+178.7%$2.39B$14M-16.3150
PRCT
PROCEPT BioRobotics
3.57 of 5 stars
$40.71
-2.1%
$74.88
+83.9%
-48.6%$2.27B$224.50M-26.26430
LMAT
LeMaitre Vascular
2.2402 of 5 stars
$95.04
-0.9%
$98.00
+3.1%
+16.4%$2.15B$219.86M46.14490Positive News
AORT
Artivion
3.5705 of 5 stars
$42.81
0.0%
$39.80
-7.0%
+75.6%$2.02B$388.54M-101.921,600Analyst Forecast
Insider Trade
EYE
National Vision
2.8254 of 5 stars
$23.87
+5.0%
$24.73
+3.6%
+142.5%$1.89B$1.82B-132.6113,411Positive News
ENOV
Enovis
4.4882 of 5 stars
$29.51
-0.1%
$51.00
+72.8%
-28.7%$1.69B$2.11B-2.077,367

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners